JR

Jayprakash Rajbali Mishra

Active Director Director DIN 07646197
DIN 07646197 First appointment Nov 2016 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Jayprakash Rajbali Mishra

Data last updated:

Jayprakash Rajbali Mishra is a Director at Remedier Pharma Private Limited (since 2016). The company operates in Business Services.

DIN 07646197
Primary Designation Director
Industry Business Services
First Appointment 07 Nov 2016
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Remedier Pharma Private Limited U74999MH2016PTC287451
Director07 Nov 20162016Active

Board colleagues of Jayprakash Rajbali Mishra

NameDINCompanyDesignation
Vinay Janardan Dixit07646100Remedier Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Remedier Pharma Private Limited
Premium access

Shareholding and investment profile for Jayprakash Rajbali Mishra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayprakash Rajbali Mishra

Jayprakash Rajbali Mishra currently holds 1 directorship: Remedier Pharma Private Limited (Director, since 07 Nov 2016).

Jayprakash Rajbali Mishra was first appointed on 07 Nov 2016 as Director at Remedier Pharma Private Limited.

The current boards of Jayprakash Rajbali Mishra's companies include Vinay Janardan Dixit (Remedier Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available